European Archives - Page 804 of 1116 - European Medical Journal

Alcohol Could Contribute to Alzheimer’s Disease

Alzheimer’s disease onset could be influenced by alcohol consumption according to researchers from the University of Illinois at Chicago, Illinois, USA.

EMJ

An interview with Shreeram Aradhye from Novartis

An interview with Shreeram Aradhye, Chief Medical Officer and Global Head, Novartis Pharmaceuticals at eyeforpharma, Barcelona 2018 who discusses….

EMJ

An interview with Amy Nicole Nayar from AbbVie

An interview with Amy Nicole Nayar, Head of Global Patient Relations, AbbVie at eyeforpharma, Barcelona 2018 who discusses the place of the patient…

EMJ 3.2 Now Available

EMJ 3.2 has entered the building! This truly multidisciplinary eJournal returns for its 10th issue and its second of 2018. EMJ 3.2 includes a plethora…

European Medical Journal 3.2 2018

EMJ 3.2 has entered the building! This truly multidisciplinary eJournal returns for its 10th issue and its second of 2018. EMJ 3.2 includes a plethora of…

Plotting a Better Pathway for Parkinson’s Disease: A New Composite Scale from My PD Journey

A clinical scale that takes a broader, deeper view of Parkinson’s disease (PD) symptoms is the latest milestone in a collaborative effort by My PD…

Delivering Precision Medicine and Patient-Centred Care Through a Multidisciplinary Approach

The current treatment strategy for patients with inflammatory bowel disease (IBD) aims to enable physicians to deliver optimal care and to improve the…

Treating Psoriasis: What Is New About Fumaric Acid Esters?

This publication covers the first session of Almirall’s 11th Skin Academy meeting in Barcelona, Spain. This year, the meeting theme was ‘The Science of…

Anti-Tumour Necrosis Factor in Inflammatory Bowel Disease: Inventory and Outlook

Biosimilars have contributed substantially to the evolving therapeutic landscape for inflammatory bowel disease (IBD), enabling healthcare systems to…

Editor's Pick: Pyruvate Kinase and Gastric Cancer: A Potential Marker

Gastric cancer is the second most common cause of cancer-related deaths worldwide, and the 5-year overall survival rate for advanced gastric cancer is ≤25%.